Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa

Identifieur interne : 001476 ( Main/Corpus ); précédent : 001475; suivant : 001477

Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa

Auteurs : Pablo Iba N Ez ; Suzanne Lesage ; Ebba Lohmann ; Ste Phane Thobois ; Giuseppe De Michele ; Michel Borg ; Yves Agid ; Alexandra Du Rr ; Alexis Brice

Source :

RBID : ISTEX:AAD5FF9203F575FC2EC4EAD14F29F93A3700A0DC

English descriptors

Abstract

Parkinson's disease is a frequent disorder caused primarily by the loss of dopaminergic neurons of the substantia nigra. Mutations in the PTEN-induced kinase (PINK1) gene, in addition to those in parkin and DJ-1, have been found in families with recessive early-onset Parkinson's disease. We screened for parkin and PINK1 mutations in a panel of 177 autosomal recessive Parkinson's disease families with ages at onset ≤60 years, mostly from Europe. In 7 unrelated families, we identified 10 pathogenic PINK1 mutations (5 missense, 2 nonsense and 3 frameshift deletion mutations), 8 of which were novel. All the mutations were in the homozygous or compound heterozygous states. Interestingly, pseudo-dominant inheritance was observed in a family with two different mutations. The clinical characteristics of 12 PINK1 patients and 114 parkin patients were similar, even for signs such as dystonia at onset and increased reflexes, which were thought to be specific to parkin. In contrast, onset in patients with PINK1 mutations was earlier and increased reflexes were found more frequently than in patients without PINK1 or parkin mutations. These results suggest that PINK1 is the second most frequent causative gene in early-onset Parkinson's disease with a slowly progressive phenotype, indistinguishable from early-onset patients with parkin mutations.

Url:
DOI: 10.1093/brain/awl005

Links to Exploration step

ISTEX:AAD5FF9203F575FC2EC4EAD14F29F93A3700A0DC

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa</title>
<author>
<name sortKey="Iba N Ez, Pablo" sort="Iba N Ez, Pablo" uniqKey="Iba N Ez P" first="Pablo" last="Iba N Ez">Pablo Iba N Ez</name>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lesage, Suzanne" sort="Lesage, Suzanne" uniqKey="Lesage S" first="Suzanne" last="Lesage">Suzanne Lesage</name>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lohmann, Ebba" sort="Lohmann, Ebba" uniqKey="Lohmann E" first="Ebba" last="Lohmann">Ebba Lohmann</name>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Thobois, Ste Phane" sort="Thobois, Ste Phane" uniqKey="Thobois S" first="Ste Phane" last="Thobois">Ste Phane Thobois</name>
<affiliation>
<mods:affiliation>Service de Neurologie C, Hôpital Neurologique de Lyon, Lyon,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Michele, Giuseppe De" sort="Michele, Giuseppe De" uniqKey="Michele G" first="Giuseppe De" last="Michele">Giuseppe De Michele</name>
<affiliation>
<mods:affiliation>Department of Neurological Sciences, Federico II University, Naples, Italy</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Borg, Michel" sort="Borg, Michel" uniqKey="Borg M" first="Michel" last="Borg">Michel Borg</name>
<affiliation>
<mods:affiliation>Service de Neurologie, CHU de Nice, Nice, France and</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Du Rr, Alexandra" sort="Du Rr, Alexandra" uniqKey="Du Rr A" first="Alexandra" last="Du Rr">Alexandra Du Rr</name>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:AAD5FF9203F575FC2EC4EAD14F29F93A3700A0DC</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1093/brain/awl005</idno>
<idno type="url">https://api.istex.fr/document/AAD5FF9203F575FC2EC4EAD14F29F93A3700A0DC/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">001476</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa</title>
<author>
<name sortKey="Iba N Ez, Pablo" sort="Iba N Ez, Pablo" uniqKey="Iba N Ez P" first="Pablo" last="Iba N Ez">Pablo Iba N Ez</name>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lesage, Suzanne" sort="Lesage, Suzanne" uniqKey="Lesage S" first="Suzanne" last="Lesage">Suzanne Lesage</name>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lohmann, Ebba" sort="Lohmann, Ebba" uniqKey="Lohmann E" first="Ebba" last="Lohmann">Ebba Lohmann</name>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Thobois, Ste Phane" sort="Thobois, Ste Phane" uniqKey="Thobois S" first="Ste Phane" last="Thobois">Ste Phane Thobois</name>
<affiliation>
<mods:affiliation>Service de Neurologie C, Hôpital Neurologique de Lyon, Lyon,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Michele, Giuseppe De" sort="Michele, Giuseppe De" uniqKey="Michele G" first="Giuseppe De" last="Michele">Giuseppe De Michele</name>
<affiliation>
<mods:affiliation>Department of Neurological Sciences, Federico II University, Naples, Italy</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Borg, Michel" sort="Borg, Michel" uniqKey="Borg M" first="Michel" last="Borg">Michel Borg</name>
<affiliation>
<mods:affiliation>Service de Neurologie, CHU de Nice, Nice, France and</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Du Rr, Alexandra" sort="Du Rr, Alexandra" uniqKey="Du Rr A" first="Alexandra" last="Du Rr">Alexandra Du Rr</name>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Brain</title>
<title level="j" type="abbrev">Brain</title>
<idno type="ISSN">0006-8950</idno>
<idno type="eISSN">1460-2156</idno>
<imprint>
<publisher>Oxford University Press</publisher>
<date type="published" when="2006-03">2006-03</date>
<biblScope unit="volume">129</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="686">686</biblScope>
<biblScope unit="page" to="694">694</biblScope>
</imprint>
<idno type="ISSN">0006-8950</idno>
</series>
<idno type="istex">AAD5FF9203F575FC2EC4EAD14F29F93A3700A0DC</idno>
<idno type="DOI">10.1093/brain/awl005</idno>
<idno type="local">awl005</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0006-8950</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>EOP = early-onset parkinsonism</term>
<term>PINK1</term>
<term>PINK1 = PTEN-induced putative kinase</term>
<term>UPDRS = Unified Parkinson's Disease Rating Scale</term>
<term>early-onset parkinsonism</term>
<term>mutation</term>
<term>parkin</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Parkinson's disease is a frequent disorder caused primarily by the loss of dopaminergic neurons of the substantia nigra. Mutations in the PTEN-induced kinase (PINK1) gene, in addition to those in parkin and DJ-1, have been found in families with recessive early-onset Parkinson's disease. We screened for parkin and PINK1 mutations in a panel of 177 autosomal recessive Parkinson's disease families with ages at onset ≤60 years, mostly from Europe. In 7 unrelated families, we identified 10 pathogenic PINK1 mutations (5 missense, 2 nonsense and 3 frameshift deletion mutations), 8 of which were novel. All the mutations were in the homozygous or compound heterozygous states. Interestingly, pseudo-dominant inheritance was observed in a family with two different mutations. The clinical characteristics of 12 PINK1 patients and 114 parkin patients were similar, even for signs such as dystonia at onset and increased reflexes, which were thought to be specific to parkin. In contrast, onset in patients with PINK1 mutations was earlier and increased reflexes were found more frequently than in patients without PINK1 or parkin mutations. These results suggest that PINK1 is the second most frequent causative gene in early-onset Parkinson's disease with a slowly progressive phenotype, indistinguishable from early-onset patients with parkin mutations.</div>
</front>
</TEI>
<istex>
<corpusName>oup</corpusName>
<author>
<json:item>
<name>Pablo Ibáñez</name>
<affiliations>
<json:string>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</json:string>
<json:string>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Suzanne Lesage</name>
<affiliations>
<json:string>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</json:string>
<json:string>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Ebba Lohmann</name>
<affiliations>
<json:string>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</json:string>
<json:string>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Stéphane Thobois</name>
<affiliations>
<json:string>Service de Neurologie C, Hôpital Neurologique de Lyon, Lyon,</json:string>
<json:string>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Giuseppe De Michele</name>
<affiliations>
<json:string>Department of Neurological Sciences, Federico II University, Naples, Italy</json:string>
<json:string>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Michel Borg</name>
<affiliations>
<json:string>Service de Neurologie, CHU de Nice, Nice, France and</json:string>
<json:string>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Yves Agid</name>
<affiliations>
<json:string>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</json:string>
<json:string>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Alexandra Dürr</name>
<affiliations>
<json:string>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</json:string>
<json:string>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Alexis Brice</name>
<affiliations>
<json:string>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</json:string>
<json:string>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Original Articles</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>early-onset parkinsonism</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>PINK1</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>parkin</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>mutation</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>EOP = early-onset parkinsonism</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>PINK1 = PTEN-induced putative kinase</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>UPDRS = Unified Parkinson's Disease Rating Scale</value>
</json:item>
</subject>
<language>
<json:string>eng</json:string>
</language>
<abstract>Parkinson's disease is a frequent disorder caused primarily by the loss of dopaminergic neurons of the substantia nigra. Mutations in the PTEN-induced kinase (PINK1) gene, in addition to those in parkin and DJ-1, have been found in families with recessive early-onset Parkinson's disease. We screened for parkin and PINK1 mutations in a panel of 177 autosomal recessive Parkinson's disease families with ages at onset ≤60 years, mostly from Europe. In 7 unrelated families, we identified 10 pathogenic PINK1 mutations (5 missense, 2 nonsense and 3 frameshift deletion mutations), 8 of which were novel. All the mutations were in the homozygous or compound heterozygous states. Interestingly, pseudo-dominant inheritance was observed in a family with two different mutations. The clinical characteristics of 12 PINK1 patients and 114 parkin patients were similar, even for signs such as dystonia at onset and increased reflexes, which were thought to be specific to parkin. In contrast, onset in patients with PINK1 mutations was earlier and increased reflexes were found more frequently than in patients without PINK1 or parkin mutations. These results suggest that PINK1 is the second most frequent causative gene in early-onset Parkinson's disease with a slowly progressive phenotype, indistinguishable from early-onset patients with parkin mutations.</abstract>
<qualityIndicators>
<score>7.912</score>
<pdfVersion>1.4</pdfVersion>
<pdfPageSize>624.307 x 804.307 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>8</keywordCount>
<abstractCharCount>1353</abstractCharCount>
<pdfWordCount>5787</pdfWordCount>
<pdfCharCount>35597</pdfCharCount>
<pdfPageCount>9</pdfPageCount>
<abstractWordCount>201</abstractWordCount>
</qualityIndicators>
<title>Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa</title>
<genre>
<json:string>research-article</json:string>
</genre>
<host>
<volume>129</volume>
<pages>
<last>694</last>
<first>686</first>
</pages>
<issn>
<json:string>0006-8950</json:string>
</issn>
<issue>3</issue>
<genre></genre>
<language>
<json:string>unknown</json:string>
</language>
<eissn>
<json:string>1460-2156</json:string>
</eissn>
<title>Brain</title>
</host>
<categories>
<wos>
<json:string>CLINICAL NEUROLOGY</json:string>
<json:string>NEUROSCIENCES</json:string>
</wos>
</categories>
<publicationDate>2006</publicationDate>
<copyrightDate>2006</copyrightDate>
<doi>
<json:string>10.1093/brain/awl005</json:string>
</doi>
<id>AAD5FF9203F575FC2EC4EAD14F29F93A3700A0DC</id>
<fulltext>
<json:item>
<original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/AAD5FF9203F575FC2EC4EAD14F29F93A3700A0DC/fulltext/pdf</uri>
</json:item>
<json:item>
<original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/AAD5FF9203F575FC2EC4EAD14F29F93A3700A0DC/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/AAD5FF9203F575FC2EC4EAD14F29F93A3700A0DC/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Oxford University Press</publisher>
<availability>
<p>OUP</p>
</availability>
<date>2006-01-09</date>
</publicationStmt>
<notesStmt>
<note>Correspondence to: Alexis Brice, INSERM U679, Hôpital de la Salpêtrière, 47, Boulevard de l'Hôpital, 75651 Paris cedex 13, France E-mail: brice@ccr.jussieu.fr</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa</title>
<author>
<persName>
<forename type="first">Pablo</forename>
<surname>Ibáñez</surname>
</persName>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
</author>
<author>
<persName>
<forename type="first">Suzanne</forename>
<surname>Lesage</surname>
</persName>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
</author>
<author>
<persName>
<forename type="first">Ebba</forename>
<surname>Lohmann</surname>
</persName>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
</author>
<author>
<persName>
<forename type="first">Stéphane</forename>
<surname>Thobois</surname>
</persName>
<affiliation>Service de Neurologie C, Hôpital Neurologique de Lyon, Lyon,</affiliation>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
</author>
<author>
<persName>
<forename type="first">Giuseppe De</forename>
<surname>Michele</surname>
</persName>
<affiliation>Department of Neurological Sciences, Federico II University, Naples, Italy</affiliation>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
</author>
<author>
<persName>
<forename type="first">Michel</forename>
<surname>Borg</surname>
</persName>
<affiliation>Service de Neurologie, CHU de Nice, Nice, France and</affiliation>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
</author>
<author>
<persName>
<forename type="first">Yves</forename>
<surname>Agid</surname>
</persName>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
</author>
<author>
<persName>
<forename type="first">Alexandra</forename>
<surname>Dürr</surname>
</persName>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
</author>
<author>
<persName>
<forename type="first">Alexis</forename>
<surname>Brice</surname>
</persName>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Brain</title>
<title level="j" type="abbrev">Brain</title>
<idno type="pISSN">0006-8950</idno>
<idno type="eISSN">1460-2156</idno>
<imprint>
<publisher>Oxford University Press</publisher>
<date type="published" when="2006-03"></date>
<biblScope unit="volume">129</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="686">686</biblScope>
<biblScope unit="page" to="694">694</biblScope>
</imprint>
</monogr>
<idno type="istex">AAD5FF9203F575FC2EC4EAD14F29F93A3700A0DC</idno>
<idno type="DOI">10.1093/brain/awl005</idno>
<idno type="local">awl005</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2006-01-09</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>Parkinson's disease is a frequent disorder caused primarily by the loss of dopaminergic neurons of the substantia nigra. Mutations in the PTEN-induced kinase (PINK1) gene, in addition to those in parkin and DJ-1, have been found in families with recessive early-onset Parkinson's disease. We screened for parkin and PINK1 mutations in a panel of 177 autosomal recessive Parkinson's disease families with ages at onset ≤60 years, mostly from Europe. In 7 unrelated families, we identified 10 pathogenic PINK1 mutations (5 missense, 2 nonsense and 3 frameshift deletion mutations), 8 of which were novel. All the mutations were in the homozygous or compound heterozygous states. Interestingly, pseudo-dominant inheritance was observed in a family with two different mutations. The clinical characteristics of 12 PINK1 patients and 114 parkin patients were similar, even for signs such as dystonia at onset and increased reflexes, which were thought to be specific to parkin. In contrast, onset in patients with PINK1 mutations was earlier and increased reflexes were found more frequently than in patients without PINK1 or parkin mutations. These results suggest that PINK1 is the second most frequent causative gene in early-onset Parkinson's disease with a slowly progressive phenotype, indistinguishable from early-onset patients with parkin mutations.</p>
</abstract>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>KWD</head>
<item>
<term>early-onset parkinsonism</term>
</item>
<item>
<term>PINK1</term>
</item>
<item>
<term>parkin</term>
</item>
<item>
<term>mutation</term>
</item>
</list>
</keywords>
</textClass>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>ABR</head>
<item>
<term>EOP = early-onset parkinsonism</term>
</item>
<item>
<term>PINK1 = PTEN-induced putative kinase</term>
</item>
<item>
<term>UPDRS = Unified Parkinson's Disease Rating Scale</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2006-01-09">Created</change>
<change when="2006-03">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/AAD5FF9203F575FC2EC4EAD14F29F93A3700A0DC/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="corpus oup" wicri:toSee="no header">
<istex:xmlDeclaration>version="1.0" encoding="US-ASCII"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" URI="journalpublishing.dtd" name="istex:docType"></istex:docType>
<istex:document>
<article xml:lang="en" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="hwp">brain</journal-id>
<journal-id journal-id-type="nlm-ta">Brain</journal-id>
<journal-id journal-id-type="publisher-id">brainj</journal-id>
<journal-title>Brain</journal-title>
<abbrev-journal-title abbrev-type="publisher">Brain</abbrev-journal-title>
<issn pub-type="ppub">0006-8950</issn>
<issn pub-type="epub">1460-2156</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="other">awl005</article-id>
<article-id pub-id-type="doi">10.1093/brain/awl005</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mutational analysis of the
<italic>PINK1</italic>
gene in early-onset parkinsonism in Europe and North Africa</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ibáñez</surname>
<given-names>Pablo</given-names>
</name>
<xref rid="AFF1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lesage</surname>
<given-names>Suzanne</given-names>
</name>
<xref rid="AFF1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lohmann</surname>
<given-names>Ebba</given-names>
</name>
<xref rid="AFF1">1</xref>
<xref rid="AFF3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thobois</surname>
<given-names>Stéphane</given-names>
</name>
<xref rid="AFF5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Michele</surname>
<given-names>Giuseppe De</given-names>
</name>
<xref rid="AFF7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Borg</surname>
<given-names>Michel</given-names>
</name>
<xref rid="AFF6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Agid</surname>
<given-names>Yves</given-names>
</name>
<xref rid="AFF1">1</xref>
<xref rid="AFF3">3</xref>
<xref rid="AFF4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dürr</surname>
<given-names>Alexandra</given-names>
</name>
<xref rid="AFF1">1</xref>
<xref rid="AFF2">2</xref>
<xref rid="AFF3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brice</surname>
<given-names>Alexis</given-names>
</name>
<xref rid="AFF1">1</xref>
<xref rid="AFF2">2</xref>
<xref rid="AFF3">3</xref>
<xref rid="AFF4">4</xref>
</contrib>
<contrib contrib-type="group-author">
<on-behalf-of>and the French Parkinson's Disease Genetics Study Group</on-behalf-of>
</contrib>
<aff>
<target target-type="aff" id="AFF1"></target>
<label>1</label>
INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,
<target target-type="aff" id="AFF2"></target>
<label>2</label>
Département de Génétique, Cytogénétique et Embryologie, CHU Pitié-Salpêtrière,
<target target-type="aff" id="AFF3"></target>
<label>3</label>
Fédération de Neurologie, CHU Pitié-Salpêtrière,
<target target-type="aff" id="AFF4"></target>
<label>4</label>
UFR, CHU Pitié-Salpêtrière, Paris,
<target target-type="aff" id="AFF5"></target>
<label>5</label>
Service de Neurologie C, Hôpital Neurologique de Lyon, Lyon,
<target target-type="aff" id="AFF6"></target>
<label>6</label>
Service de Neurologie, CHU de Nice, Nice, France and
<target target-type="aff" id="AFF7"></target>
<label>7</label>
Department of Neurological Sciences, Federico II University, Naples, Italy</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence to: Alexis Brice, INSERM U679, Hôpital de la Salpêtrière, 47, Boulevard de l'Hôpital, 75651 Paris cedex 13, France E-mail:
<ext-link xlink:href="brice@ccr.jussieu.fr" ext-link-type="email">brice@ccr.jussieu.fr</ext-link>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>March</month>
<year>2006</year>
</pub-date>
<pub-date pub-type="epub">
<day>9</day>
<month>1</month>
<year>2006</year>
</pub-date>
<volume>129</volume>
<issue>3</issue>
<fpage>686</fpage>
<lpage>694</lpage>
<history>
<date date-type="accepted">
<day>9</day>
<month>12</month>
<year>2005</year>
</date>
<date date-type="received">
<day>9</day>
<month>9</month>
<year>2005</year>
</date>
<date date-type="rev-recd">
<day>8</day>
<month>12</month>
<year>2005</year>
</date>
</history>
<copyright-statement>Published by Oxford University Press on behalf of the Guarantors of Brain. For Permissions, please email: journals.permissions@oxfordjournals.org</copyright-statement>
<copyright-year>2006</copyright-year>
<abstract xml:lang="en">
<p>Parkinson's disease is a frequent disorder caused primarily by the loss of dopaminergic neurons of the
<italic>substantia nigra</italic>
. Mutations in the PTEN-induced kinase (
<italic>PINK1</italic>
) gene, in addition to those in
<italic>parkin</italic>
and
<italic>DJ-1</italic>
, have been found in families with recessive early-onset Parkinson's disease. We screened for
<italic>parkin</italic>
and
<italic>PINK1</italic>
mutations in a panel of 177 autosomal recessive Parkinson's disease families with ages at onset ≤60 years, mostly from Europe. In 7 unrelated families, we identified 10 pathogenic
<italic>PINK1</italic>
mutations (5 missense, 2 nonsense and 3 frameshift deletion mutations), 8 of which were novel. All the mutations were in the homozygous or compound heterozygous states. Interestingly, pseudo-dominant inheritance was observed in a family with two different mutations. The clinical characteristics of 12 PINK1 patients and 114 parkin patients were similar, even for signs such as dystonia at onset and increased reflexes, which were thought to be specific to
<italic>parkin</italic>
. In contrast, onset in patients with
<italic>PINK1</italic>
mutations was earlier and increased reflexes were found more frequently than in patients without
<italic>PINK1</italic>
or
<italic>parkin</italic>
mutations. These results suggest that
<italic>PINK1</italic>
is the second most frequent causative gene in early-onset Parkinson's disease with a slowly progressive phenotype, indistinguishable from early-onset patients with
<italic>parkin</italic>
mutations.</p>
</abstract>
<kwd-group kwd-group-type="KWD" xml:lang="en">
<kwd>early-onset parkinsonism</kwd>
<kwd>
<italic>PINK1</italic>
</kwd>
<kwd>
<italic>parkin</italic>
</kwd>
<kwd>mutation</kwd>
</kwd-group>
<kwd-group kwd-group-type="ABR" xml:lang="en">
<kwd>EOP = early-onset parkinsonism</kwd>
<kwd>PINK1 = PTEN-induced putative kinase</kwd>
<kwd>UPDRS = Unified Parkinson's Disease Rating Scale</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>hwp-legacy-fpage</meta-name>
<meta-value>686</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>March 2006</meta-value>
</custom-meta>
<custom-meta>
<meta-name>hwp-legacy-dochead</meta-name>
<meta-value>Original Article</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
</article>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa</title>
</titleInfo>
<titleInfo type="alternative" lang="en" contentType="CDATA">
<title>Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa</title>
</titleInfo>
<name type="personal">
<namePart type="given">Pablo</namePart>
<namePart type="family">Ibáñez</namePart>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Suzanne</namePart>
<namePart type="family">Lesage</namePart>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Ebba</namePart>
<namePart type="family">Lohmann</namePart>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Stéphane</namePart>
<namePart type="family">Thobois</namePart>
<affiliation>Service de Neurologie C, Hôpital Neurologique de Lyon, Lyon,</affiliation>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Giuseppe De</namePart>
<namePart type="family">Michele</namePart>
<affiliation>Department of Neurological Sciences, Federico II University, Naples, Italy</affiliation>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Michel</namePart>
<namePart type="family">Borg</namePart>
<affiliation>Service de Neurologie, CHU de Nice, Nice, France and</affiliation>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Yves</namePart>
<namePart type="family">Agid</namePart>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Alexandra</namePart>
<namePart type="family">Dürr</namePart>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Alexis</namePart>
<namePart type="family">Brice</namePart>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<affiliation>INSERM U679 (former U289), Neurologie et Thérapeutique Expérimentale, CHU Pitié-Salpêtrière,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="research-article"></genre>
<originInfo>
<publisher>Oxford University Press</publisher>
<dateIssued encoding="w3cdtf">2006-03</dateIssued>
<dateCreated encoding="w3cdtf">2006-01-09</dateCreated>
<copyrightDate encoding="w3cdtf">2006</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
</physicalDescription>
<abstract lang="en">Parkinson's disease is a frequent disorder caused primarily by the loss of dopaminergic neurons of the substantia nigra. Mutations in the PTEN-induced kinase (PINK1) gene, in addition to those in parkin and DJ-1, have been found in families with recessive early-onset Parkinson's disease. We screened for parkin and PINK1 mutations in a panel of 177 autosomal recessive Parkinson's disease families with ages at onset ≤60 years, mostly from Europe. In 7 unrelated families, we identified 10 pathogenic PINK1 mutations (5 missense, 2 nonsense and 3 frameshift deletion mutations), 8 of which were novel. All the mutations were in the homozygous or compound heterozygous states. Interestingly, pseudo-dominant inheritance was observed in a family with two different mutations. The clinical characteristics of 12 PINK1 patients and 114 parkin patients were similar, even for signs such as dystonia at onset and increased reflexes, which were thought to be specific to parkin. In contrast, onset in patients with PINK1 mutations was earlier and increased reflexes were found more frequently than in patients without PINK1 or parkin mutations. These results suggest that PINK1 is the second most frequent causative gene in early-onset Parkinson's disease with a slowly progressive phenotype, indistinguishable from early-onset patients with parkin mutations.</abstract>
<note type="author-notes">Correspondence to: Alexis Brice, INSERM U679, Hôpital de la Salpêtrière, 47, Boulevard de l'Hôpital, 75651 Paris cedex 13, France E-mail: brice@ccr.jussieu.fr</note>
<subject lang="en">
<genre>KWD</genre>
<topic>early-onset parkinsonism</topic>
<topic>PINK1</topic>
<topic>parkin</topic>
<topic>mutation</topic>
</subject>
<subject lang="en">
<genre>ABR</genre>
<topic>EOP = early-onset parkinsonism</topic>
<topic>PINK1 = PTEN-induced putative kinase</topic>
<topic>UPDRS = Unified Parkinson's Disease Rating Scale</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Brain</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>Brain</title>
</titleInfo>
<genre type="Journal">journal</genre>
<identifier type="ISSN">0006-8950</identifier>
<identifier type="eISSN">1460-2156</identifier>
<identifier type="PublisherID">brainj</identifier>
<identifier type="PublisherID-hwp">brain</identifier>
<identifier type="PublisherID-nlm-ta">Brain</identifier>
<part>
<date>2006</date>
<detail type="volume">
<caption>vol.</caption>
<number>129</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>3</number>
</detail>
<extent unit="pages">
<start>686</start>
<end>694</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">AAD5FF9203F575FC2EC4EAD14F29F93A3700A0DC</identifier>
<identifier type="DOI">10.1093/brain/awl005</identifier>
<identifier type="local">awl005</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Published by Oxford University Press on behalf of the Guarantors of Brain. For Permissions, please email: journals.permissions@oxfordjournals.org</accessCondition>
<recordInfo>
<recordContentSource>OUP</recordContentSource>
</recordInfo>
</mods>
</metadata>
<covers>
<json:item>
<original>true</original>
<mimetype>image/tiff</mimetype>
<extension>tiff</extension>
<uri>https://api.istex.fr/document/AAD5FF9203F575FC2EC4EAD14F29F93A3700A0DC/covers/tiff</uri>
</json:item>
<json:item>
<original>true</original>
<mimetype>text/html</mimetype>
<extension>html</extension>
<uri>https://api.istex.fr/document/AAD5FF9203F575FC2EC4EAD14F29F93A3700A0DC/covers/html</uri>
</json:item>
</covers>
<annexes>
<json:item>
<original>true</original>
<mimetype>image/jpeg</mimetype>
<extension>jpeg</extension>
<uri>https://api.istex.fr/document/AAD5FF9203F575FC2EC4EAD14F29F93A3700A0DC/annexes/jpeg</uri>
</json:item>
<json:item>
<original>true</original>
<mimetype>image/gif</mimetype>
<extension>gif</extension>
<uri>https://api.istex.fr/document/AAD5FF9203F575FC2EC4EAD14F29F93A3700A0DC/annexes/gif</uri>
</json:item>
</annexes>
<enrichments>
<istex:catWosTEI uri="https://api.istex.fr/document/AAD5FF9203F575FC2EC4EAD14F29F93A3700A0DC/enrichments/catWos">
<teiHeader>
<profileDesc>
<textClass>
<classCode scheme="WOS">CLINICAL NEUROLOGY</classCode>
<classCode scheme="WOS">NEUROSCIENCES</classCode>
</textClass>
</profileDesc>
</teiHeader>
</istex:catWosTEI>
</enrichments>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001476 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001476 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:AAD5FF9203F575FC2EC4EAD14F29F93A3700A0DC
   |texte=   Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024